Canopy Growth (TSX:WEED) and Skinvisible Pharmaceuticals (OTCQB:SKVI) has announced the signing of a definitive license agreement for Skinvisible's patented topical formulations. As quoted in the press release: Per the agreement, Canopy Growth is exclusively licensed to distribute Skinvisible's topical products in Canada, and shall have a first right of refusal for all other countries, excluding …